sales to EGAT increased 6.2% y-on-y and 3.5% q-on-q (3.07 Baht/KWh in 2018 / 3.24 Baht/KWh in Q4’2018) because the energy payment is generally adjusted to reflect changes in natural gas price which rose
period. Electricity price sales to EGAT increased 1.7% y-on-y and 4.5% q-on-q (2.94 Baht/KWh in 6M’2018 / 3.01 Baht/KWh in Q2’2018) because the energy payment is generally adjusted to reflect changes in
sales to EGAT increased 3.4% y-on-y and 3.0% q-on-q (3.00 Baht/KWh in 9M’2018 / 3.10 Baht/KWh in Q3’2018) because the energy payment is generally adjusted to reflect changes in natural gas price
gains/losses wherein inventory gains decrease the cost of sales and inventory losses increase the cost of sales. Core Net Profit is the Reported Net Profit less extraordinary items less tax adjusted
less extraordinary items less tax adjusted inventory gain/loss. Net Operating Debt is Net Debt (total debt less cash and current investments) less cash outflow for the various projects underway which are
Company Limited as of 31st December 2019 as follows: A. Book value B. Adjusted book value based on market value C. Discounted cash flow method Value of shares of Modern Pharma Company Limited based on
รวมค่ำตัด จ ำหน่ำย (Adjusted Net Income)3 1,441 1,948 2,264 57% 16% 2,383 4,212 77% อัตรำก ำไรขัน้ต้น (%) 30% 29% 31% 1% 2% 29% 30% 1% อัตรำก ำไรสุทธิ (%) 5% 9% 10% 5% 2% 7% 11% 4% Adjusted Net Income
will be adjusted to increase or decrease from cash or cash equivalent, account receivebles and other receivables, other current assets minus the account payables and other payables, current liabilities
บริษัทใหญ่ ท่ีไม่รวมค่ำตัด จ ำหน่ำย (Adjusted Net Income)3 1,265 2,264 2,937 132% 30% 3,648 7,149 96% อัตรำก ำไรขัน้ต้น (%) 28% 31% 32% 4% 1% 29% 31% 2% อัตรำก ำไรสุทธิ (%) 5% 10% 16% 11% 5% 6% 13% 7
or 12.2% from planned shutdown and decrease in unit rate which is adjusted in line with the decline in average natural gas price. Sales and service income for Q4/2020 compared to Q3/2020 decrease by